Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
. 2001 Feb 28;27(3):197-206.
doi: 10.1016/s0212-6567(01)78797-5.

[The COMBO project. Criteria and guidelines for the combined treatment of type 2 diabetes. Consensus document (I)]

[Article in Spanish]
A Goday Arno, J Franch Nadal, M Mata Cases; COMBO Project
Guideline

[The COMBO project. Criteria and guidelines for the combined treatment of type 2 diabetes. Consensus document (I)]

[Article in Spanish]
A Goday Arno et al. Aten Primaria. .
No abstract available

PubMed Disclaimer

References

Bibliografía General

    1. Klein R. Hyperglicemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995;18:258–268. - PubMed
    1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med. 1993;329:977–986. - PubMed
    1. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6 years study. Diabetes Res Clin Frac. 1995;28:103–117. - PubMed
    1. United Kingdom Prospective Diabetes Study Group Intensive blood-glucose control with sulfonilureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352:837–852. - PubMed
    1. United Kingdom Prospective Diabetes Study Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet. 1998;352:854–864. - PubMed
Bibliografía Monoterapia
    1. Lebovitz H.E. Insulin secretagogues: old and new. Diabetes Rev. 1999;7:139–153.
    1. Turner R., Cull C., Holman R. UK Prospective Diabetes Study 17: a nine-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non insulin-dependent diabetes mellitus. Ann Intern Med. 1996;124:136–145. - PubMed
    1. Rosenstock J., Samols E., Muchmore D.B., Schneider J. The Glymepiride Study Group. Glymepiride, a new once-daily suifonylurea: a double-blind placebo-controlled study of NIDDM patients. Diabetes Care. 1996;19:1194–1200. - PubMed
    1. Draeger K.E., Wernicke-Panten K., Lomp H.J., Schuler E., Rosskamp R. Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glymepiride (Amaryl): a double-blind comparison with glibenclamide. Horm Metab Res. 1996;28:419–425. - PubMed
    1. Goldberg R.B., Holvey S.M. Schnelder. A dose-response study of glymepiride in patients with NIDDM who have previously received sulfonylurea agents. Diabetes Care. 1996;19:849–856. - PubMed

MeSH terms